Uterine Corpus Leiomyosarcoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Uterine Corpus Leiomyosarcoma

subtype

Identifier: CI-CAN-00007028
Entity page: /cancer/uterine-corpus-leiomyosarcoma ↗
Edges: 42

Neighbours: 20 drugs10 trials
Drawn: 30 of 30 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Uterine Corpus Leiomyosarcoma investigated in trials for …INVESTIGATED_IN_TRIALSderived20 of 20show fewer
→ investigated in trials for	Docetaxelsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Uterine Corpus Leiomyosarcoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall molecule

Uterine Corpus Leiomyosarcoma studied in …STUDIED_INderived10 of 22show all (up to 200)
→ studied in	NCT06524583Phase 2 · recruiting Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Uterine Corpus Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01012297Phase 3 · terminated Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 22 trials mapped (5 active)	—	—	Uterine Corpus Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07467772Phase 2 · recruiting Ph 2 Elacestrant in ER Positive Uterine Sarcomas · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Uterine Corpus Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04200443Phase 2 · active not recruiting Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 22 trials mapped (5 active)	—	—	Uterine Corpus Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01793168recruiting Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Uterine Corpus Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02428192Phase 2 · completed Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma · condition mapped ONTOLOGY_EXACT · 22 trials mapped (5 active)	—	—	Uterine Corpus Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03926936Phase 2 · completed FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Uterine Corpus Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06244251NA · active not recruiting Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Uterine Corpus Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01958580NA · terminated Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery · condition mapped ONTOLOGY_EXACT · 22 trials mapped (5 active)	—	—	Uterine Corpus Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02601209Phase 1/Phase 2 · terminated Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma · condition mapped CURATED_BROADER · 22 trials mapped (5 active)	—	—	Uterine Corpus Leiomyosarcoma	1	Observed	clinicaltrials	graph →